David A. Pierce - 04 Jan 2022 Form 4 Insider Report for BOSTON SCIENTIFIC CORP (BSX)

Role
EVP Pres MedSurg
Signature
/s/ Vance R. Brown, Attorney-in-fact
Issuer symbol
BSX
Transactions as of
04 Jan 2022
Net transactions value
-$268,230
Form type
4
Filing time
05 Jan 2022, 15:32:57 UTC
Previous filing
03 Jan 2022
Next filing
17 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BSX Common Stock Sale $268,230 -6,161 -100% $43.54 0 04 Jan 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan.
F2 Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $43.23 to $43.79, inclusive. The reporting person undertakes to provide upon request by the U.S.Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.